Peace Talks Missing Presidents
Amanpour
00:00
The Price of Prescription Drugs: A Critical Review
This chapter examines the steep costs of prescription drugs in the U.S. compared to other wealthy nations, emphasizing government efforts to reduce prices amidst significant challenges. It critiques the pharmaceutical industry's profit model, the role of public funding in drug development, and the implications of the Bayh-Dole Act on pricing practices. The conversation also highlights concerns surrounding drug approval processes by the FDA and calls for reform to enhance accountability and patient benefits.
Transcript
Play full episode
